Company Filing History:
1 out of 832,880 Years Active: 2004
Title: The Innovations of Didier Branellec
Introduction
Didier Branellec is a notable inventor based in Lyons, France. He has made significant contributions to the field of angiogenesis through his innovative research and patents. His work focuses on the stimulation of angiogenic activity, which is crucial for various medical applications.
Latest Patents
Didier Branellec holds a patent for "In vivo stimulation of angiogenic activity." This patent describes a method of stimulating angiogenesis by introducing two replication-deficient adenovirus vectors to the endothelial cells or nearby cells of an organism. The first vector encodes VEGF-B or a fragment thereof, while the second vector encodes VEGF-A or VEGF-C, or fragments thereof. This innovative approach has the potential to advance therapeutic strategies in regenerative medicine.
Career Highlights
Throughout his career, Didier Branellec has focused on the intersection of molecular biology and therapeutic applications. His research has contributed to a deeper understanding of how angiogenesis can be manipulated for medical benefits. With 1 patent to his name, he has established himself as a key figure in his field.
Collaborations
Didier Branellec has collaborated with esteemed colleagues such as Berndt Enholm and Seppo Ylae-Herttuala. These partnerships have enhanced his research and expanded the impact of his work in the scientific community.
Conclusion
Didier Branellec's innovative contributions to the field of angiogenesis highlight the importance of research in developing new therapeutic strategies. His patent and collaborations reflect his commitment to advancing medical science.